USP 788 Requirements and Solution. It’s as easy as 1, 2, 3…
Start with this USP 788 overview paper
This paper discusses the requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards and includes the most recent USP 788 (USP 42 2018), EP 5.1 and JP 17 release information. These standards demand that injectable solutions are effectively monitored for microcontamination, specifically non-soluble particulates.
Watch this On-Demand webinar for an overview of the requirements and a solution
Other Webinars to consider: